Breaking News

PCI Pharma Services Acquires LSNE

Adds end-to-end global sterile fill-finish and lyophilization manufacturing capabilities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PCI Pharma Services (PCI), a pharmaceutical and biopharmaceutical global integrated solutions provider, has signed a definitive agreement to acquire Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization (CDMO) headquartered in Bedford, NH, from global private equity firm Permira.   Founded in 1997, LSNE serves global pharmaceutical, biotechnology and medical device companies, offering high-quality cGMP aseptic fill-finish capabilitie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters